MoneyWorks4Me

Alembic Pharmaceuticals gets nod to raise up to Rs 1,000 crore via QIP

27 Jul 2020 Evaluate
Alembic Pharmaceuticals has received an approval to raise up to Rs 1,000 crore through a qualified institutions placement (QIP). The board, at its meeting, has accorded its approval to raise up to Rs 1,000 crore through a QIP issue of equity shares.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..